Model Number 37714 |
Device Problems
Delayed Charge Time (2586); Battery Problem (2885); Charging Problem (2892); Insufficient Information (3190)
|
Patient Problems
Sleep Dysfunction (2517); No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 12/21/2020 |
Event Type
malfunction
|
Manufacturer Narrative
|
If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Information was received from a patient who was implanted with an implantable neurostimulator (ins) for non-malignant pain and post lumbar laminectomy syndrome.The reason for call was pt states his battery will not take a charge, pt states he sees the reposition antenna screen and this has been going for a month.Pss advised to try programmer and pt gets warning screen to charge.Pt gets the reposition antenna screen on the recharger screen.Pt states taking longer to charge the last couple of months and this last month not taking a charge at all.Pss reviewed battery is so low and needs to charge before goes into an overdischarge.Pt was seeing power on reset (por) while charging, pss walked through how to charge and pt was charging with 2 boxes shaded.Pss reviewed will eventually have to clear por message on remote.Pss advised to try and charge by turning dial, etc the troubleshooting steps that were taken on the call resolved the issue.No patient symptoms were reported.
|
|
Manufacturer Narrative
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Additional information was received from the patient reporting that the last time they talked with their healthcare provider (hcp) they told them to talked to the person ahead of their case (possibly their manufacturer representative (rep)).The patient repeated that it took them almost a day to charge their ins and that the charge only lasted 2 to 3 hours.It was discussed with the patient that the implant would probably need to be replaced.The patient stated that they would talk to their surgeon.The patient was now checking on the status.
|
|
Manufacturer Narrative
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Additional information was reported that for about a year the patient's charge duration increased from 3 or 4 hours to 12 hours and their charge frequency changed from every 2 or 3 days to their ins charge not lasting through the night.Patient said that their health care provider (hcp) is for pain and they have a difficult time sleeping without their ins.The patient noted to continue to see receive por.The patient also noted seeing elective removal indicator (eri).The patient was redirected to their healthcare provider to further address the issue.
|
|
Manufacturer Narrative
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Additional information received from the patient indicated that the ins has been taking longer and longer over the past couple years to charge.They stated it takes 10-12 hours to charge and lasts only 4-5 hours.They noted that they will hopefully have the device replaced, but the issue has not been resolved at this time.
|
|
Search Alerts/Recalls
|